Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218935
Max Phase: Preclinical
Molecular Formula: C20H11BrCl3N3O2
Molecular Weight: 511.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3218935
Max Phase: Preclinical
Molecular Formula: C20H11BrCl3N3O2
Molecular Weight: 511.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1nc2ccc(Br)cn2cc1Cc1cccc(Oc2nc(Cl)c(Cl)cc2Cl)c1
Standard InChI: InChI=1S/C20H11BrCl3N3O2/c21-13-4-5-17-25-19(28)12(9-27(17)10-13)6-11-2-1-3-14(7-11)29-20-16(23)8-15(22)18(24)26-20/h1-5,7-10H,6H2
Standard InChI Key: KGEQRAWIRMPHOH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 511.59 | Molecular Weight (Monoisotopic): 508.9100 | AlogP: 6.20 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.79 | CX LogD: 5.79 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -1.23 |
1. Rapolu S, Alla M, Ganji RJ, Saddanapu V, Kishor C, Bommena VR, Addlagatta A. (2013) Synthesis, cytotoxicity and hDHFR inhibition studies of 2H-pyrido[1,2-a]pyrimidin-2-ones, 4 (5): [10.1039/C3MD00013C] |
Source(1):